Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid

International Journal of Dermatology

Volumn 42, Issue 9, 2003, Pages 703-706

  Motta, Ana Carolina F ^a   Arruda, Darlene ^a   Souza, Cacilda S ^a   Foss, Norma T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLICLAZIDE; MEGLUMINE ANTIMONATE; PREDNISONE;

AGED; ANAMNESIS; CASE REPORT; CHRONIC DRUG ADMINISTRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; ERYTHEMA; FACE; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; INGUINAL LYMPH NODE; LABORATORY TEST; LEISHMANIA BRAZILIENSIS; LYMPHADENOPATHY; MALE; MOUTH MUCOSA; MOUTH ULCER; PAPULE; PHYSICAL EXAMINATION; SCAR; SKIN DEFECT; SKIN LEISHMANIASIS; SKIN ULCER; SUBMANDIBULAR GLAND;

AGED; ANIMALS; ANTIPROTOZOAL AGENTS; DIAGNOSIS, DIFFERENTIAL; FACIAL DERMATOSES; HUMANS; IMMUNOCOMPROMISED HOST; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, MUCOCUTANEOUS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PREDNISONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 0141482129     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01730.x     Document Type: Conference Paper

References (15)

1. Abbas K, Toum IA, Hassan AM. Oral leishmaniasis associated with kala-azar. A case report. Oral Surg Oral Med Oral Pathol 1992; 73: 583-584.
2. V+): Intralesional canine tegumentary leishmaniasis therapy. Parasite 1998; 5: 175-180.
3. WHO. Control of the Leishmaniasis: World Health Organization Technical Report Series 793. Geneva: World Health Organization, 1990.
4. Pirmez M. Immunopathology of American cutaneous leishmaniasis, Rio Janeiro, Brazil. Mem Inst Oswaldo Cruz 1992; 87 (Suppl.): 105-109.
5. Falqueto A, Sessa PA. Leishmaniose Tegumentar Americana. In: Veronese R, ed. Tratado de Infectologia. São Paulo, SP, Brazil: Atheneu, 1997: 1221-1233.
6. Pirmez C, Trajano VS, Paes-Oliveira Neto M, et al. Use of PCR in diagnosis of human American tegumentary leishmaniasis in Rio de Janeiro, Brazil. J Clin Microbiol 1999; 37: 1819-1823.
7. Marsden PD. Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis in Três Braços, Bahia-Brazil. Rev Soc Bras Med Trop 1994; 27: 93-101.
8. Moraes MA, Correia Filho D, Santos JB. Lymphadenopathies in American cutaneous leishmaniasis. Comments on 2 cases. Rev Soc Bras Med Trop 1993; 26: 181-185.
9. Kharazmi A, Kemp K, Ismail A, et al. T-cell response in human leishmaniasis. Immunol Lett 1999; 65: 105-108.
10. + T cells in intracellular infections in humans: Leishmaniasis as an example. Immunol Today 1996; 17: 13-20.
11. Costa JML, Marsden PD, Llanos-Cuentas EA, et al. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: A report of eight cases. J Trop Med Hyg 1986; 89: 319-323.
12. Goto H, Sotto MN, Corbett CEP, et al. A case of multiple lesion mucocutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis infection. J Trop Med Hig 1990; 93: 48-51.
13. Marsden PD. Endemic leishmaniasis in Brazil: Future implications. Mem Inst Oswaldo Cruz 1994; 89: 425-426.
14. Tolezano JE. Ecoepidemiological aspects of American cutaneous leishmaniasis in the state of São Paulo, Brazil. Mem Inst Oswaldo Cruz 1994; 89: 427-434.
15. Pupo Nogueira Neto J, Basso G, Cipoli A, El Kadre L. American cutaneous leishmaniasis in the State of São Paulo, Brazil - Epidemiology in transformation. Ann Agric Environ Med 1998; 5: 1-5.